Project Grant T32DK138883
- This federal Project Grant award in the amount of $314,166 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional T32 training program in Pediatric Endocrinology at the University of Pittsburgh's Children's Hospital. The program aims to expand training opportunities,...
- This federal Project Grant award of $108,000.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the Michigan Summer Undergraduate Research Experience: Diabetes & Metabolic Diseases (M-SURE) program at the Regents of the University of Michigan. The program aims to recruit 14 undergraduate trainees annually for a summer research experience, mentored...
- This Project Grant award of $1,835,461.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports the operations of the UCSF Diabetes Research Center (DRC). The DRC functions as a comprehensive basic and clinical research enterprise dedicated to advancing the understanding and treatment of Type 1 Diabetes (T1D). Key activities funded under this award include an...
- The University of Chicago was awarded a $249,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research program) with a project period from May 1, 2025 to April 30, 2028. The grant will fund research to characterize the m6A methylome of aging B-cells and identify m6A-regulated pathways underlying accelerated B-cell senescence in diabetes. The overarching goal is to determine if m6A is a...
- This federal Project Grant award of $801,662, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research by the Scripps Research Institute to investigate the early phase of type 1 diabetes. The key objectives are to characterize the antigen-presenting cells associated with pancreatic islets during the pre-diabetic stage in mice, using advanced techniques...
- The University of California, Los Angeles (UCLA) was awarded a $367,599 Project Grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, titled "UCLA Interdisciplinary Training Program in Metabolism (UCLA-ITPM)," aims to train up to 6 scientists over a 2-year period to advance prevention, treatment, and clinical care for metabolism-related diseases....
- This Project Grant award of $223,176 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a research project titled "The Contribution of Mitochondrial DNA Damage to Diabetes-Related Beta-Cell Failure". The award, which runs from December 27, 2024 to August 31, 2026, provides funding for Dr. Rebecca Davidson, a postdoctoral research fellow at the University of Michigan, to...
- This federal Project Grant award of $803,748 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant is funding research to investigate the modulation of insulin signaling in adipocytes (fat cells) and how improved adipocyte insulin sensitivity can contribute to positive metabolic outcomes. The research team at The University of Texas Southwestern Medical...
- This $847,746 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports research by the Beckman Research Institute of the City of Hope to investigate the role of the UPR transducer XBP1 in pancreatic beta cell survival and function under metabolic stress. The research aims to identify the "tilting point" of the unfolded protein response (UPR) under metabolic stress and explore its potential for therapeutic interventions for...
- The University of California, Davis received a $126,480 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to conduct research on the role of the signaling protein 14-3-3-z in regulating the crosstalk between pancreatic islet cells. The research aims to define a new pathway regulating 14-3-3-z expression in beta cells and investigate how this impacts alpha cell function and glucose-stimulated insulin secretion. This project is expected...
This Project Grant award, valued at $188,428 and granted by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), supports an Interdisciplinary Training Program in Diabetes and Metabolism Research at the University of Arizona. The program aims to deliver a contemporary training experience in physiological diabetes research, applied research skills, community engagement, and career development. Key focus areas include the molecular basis of diabetes, pathogenesis mechanisms, complications, and community-engaged research. The program leverages state-of-the-art facilities, research centers, and institutional resources to provide trainees with integrated mentoring and translational research opportunities spanning the spectrum of diabetes research. The award has a project period from September 1, 2025 through June 30, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $188.4k | 8/25/25 |